Cargando…

Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life

BACKGROUND: Children who take methotrexate for juvenile idiopathic arthritis may experience side effects, including nausea and vomiting, leading to anticipatory nausea in some children, and fear of injections or blood tests. The aim of this study was to examine the prevalence and extent of these dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulligan, Kathleen, Kassoumeri, Laura, Etheridge, Angela, Moncrieffe, Halima, Wedderburn, Lucy R, Newman, Stanton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679741/
https://www.ncbi.nlm.nih.gov/pubmed/23714105
http://dx.doi.org/10.1186/1546-0096-11-23
_version_ 1782273005919928320
author Mulligan, Kathleen
Kassoumeri, Laura
Etheridge, Angela
Moncrieffe, Halima
Wedderburn, Lucy R
Newman, Stanton
author_facet Mulligan, Kathleen
Kassoumeri, Laura
Etheridge, Angela
Moncrieffe, Halima
Wedderburn, Lucy R
Newman, Stanton
author_sort Mulligan, Kathleen
collection PubMed
description BACKGROUND: Children who take methotrexate for juvenile idiopathic arthritis may experience side effects, including nausea and vomiting, leading to anticipatory nausea in some children, and fear of injections or blood tests. The aim of this study was to examine the prevalence and extent of these difficulties and their impact on quality of life. METHODS: Participants were mothers of children with JIA who were currently taking methotrexate (MTX). Mothers completed a questionnaire about MTX that was developed for the study, two questions from the treatment subscale of the Pediatric Quality of Life Inventory (PedsQL) Rheumatology scale to assess needle-related problems and the Child Health Questionnaire 50-item parent version (CHQ-PF50) to assess health-related quality of life (HRQoL). RESULTS: 171 mothers participated in the study. More than half of children were reported to have experienced one or more of: nausea or vomiting after taking MTX, anticipatory nausea, fear of blood tests or fear of injections. There was no significant difference in reported rates of sickness or needle-related problems between MTX responders (ACR70 or above), partial responders (ACR30 or ACR50) and non-responders. In multivariate analyses, variables that were significant independent predictors of one or more MTX-related difficulties included younger age, taking MTX subcutaneously and having a larger number of currently active joints. Feeling sick after taking MTX was a significant independent predictor of poorer scores on the physical summary scale of the CHQ-PF50. Anxiety about injections and feeling sick after taking MTX were significant independent predictors of poorer scores on the psychosocial summary scale. CONCLUSIONS: Difficulties in taking MTX are experienced by a significant proportion of children with JIA and these may have an adverse impact on HRQoL. Approaches to help minimize these difficulties are required.
format Online
Article
Text
id pubmed-3679741
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36797412013-06-13 Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life Mulligan, Kathleen Kassoumeri, Laura Etheridge, Angela Moncrieffe, Halima Wedderburn, Lucy R Newman, Stanton Pediatr Rheumatol Online J Research BACKGROUND: Children who take methotrexate for juvenile idiopathic arthritis may experience side effects, including nausea and vomiting, leading to anticipatory nausea in some children, and fear of injections or blood tests. The aim of this study was to examine the prevalence and extent of these difficulties and their impact on quality of life. METHODS: Participants were mothers of children with JIA who were currently taking methotrexate (MTX). Mothers completed a questionnaire about MTX that was developed for the study, two questions from the treatment subscale of the Pediatric Quality of Life Inventory (PedsQL) Rheumatology scale to assess needle-related problems and the Child Health Questionnaire 50-item parent version (CHQ-PF50) to assess health-related quality of life (HRQoL). RESULTS: 171 mothers participated in the study. More than half of children were reported to have experienced one or more of: nausea or vomiting after taking MTX, anticipatory nausea, fear of blood tests or fear of injections. There was no significant difference in reported rates of sickness or needle-related problems between MTX responders (ACR70 or above), partial responders (ACR30 or ACR50) and non-responders. In multivariate analyses, variables that were significant independent predictors of one or more MTX-related difficulties included younger age, taking MTX subcutaneously and having a larger number of currently active joints. Feeling sick after taking MTX was a significant independent predictor of poorer scores on the physical summary scale of the CHQ-PF50. Anxiety about injections and feeling sick after taking MTX were significant independent predictors of poorer scores on the psychosocial summary scale. CONCLUSIONS: Difficulties in taking MTX are experienced by a significant proportion of children with JIA and these may have an adverse impact on HRQoL. Approaches to help minimize these difficulties are required. BioMed Central 2013-05-28 /pmc/articles/PMC3679741/ /pubmed/23714105 http://dx.doi.org/10.1186/1546-0096-11-23 Text en Copyright © 2013 Mulligan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mulligan, Kathleen
Kassoumeri, Laura
Etheridge, Angela
Moncrieffe, Halima
Wedderburn, Lucy R
Newman, Stanton
Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
title Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
title_full Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
title_fullStr Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
title_full_unstemmed Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
title_short Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
title_sort mothers’ reports of the difficulties that their children experience in taking methotrexate for juvenile idiopathic arthritis and how these impact on quality of life
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679741/
https://www.ncbi.nlm.nih.gov/pubmed/23714105
http://dx.doi.org/10.1186/1546-0096-11-23
work_keys_str_mv AT mulligankathleen mothersreportsofthedifficultiesthattheirchildrenexperienceintakingmethotrexateforjuvenileidiopathicarthritisandhowtheseimpactonqualityoflife
AT kassoumerilaura mothersreportsofthedifficultiesthattheirchildrenexperienceintakingmethotrexateforjuvenileidiopathicarthritisandhowtheseimpactonqualityoflife
AT etheridgeangela mothersreportsofthedifficultiesthattheirchildrenexperienceintakingmethotrexateforjuvenileidiopathicarthritisandhowtheseimpactonqualityoflife
AT moncrieffehalima mothersreportsofthedifficultiesthattheirchildrenexperienceintakingmethotrexateforjuvenileidiopathicarthritisandhowtheseimpactonqualityoflife
AT wedderburnlucyr mothersreportsofthedifficultiesthattheirchildrenexperienceintakingmethotrexateforjuvenileidiopathicarthritisandhowtheseimpactonqualityoflife
AT newmanstanton mothersreportsofthedifficultiesthattheirchildrenexperienceintakingmethotrexateforjuvenileidiopathicarthritisandhowtheseimpactonqualityoflife